QuickView for 5-hydroxytryptamine receptor family (biogroup)

1. Drug target sets for approved compounds
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
5. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens

There were no matches for 5-hydroxytryptamine receptor family

1. Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Re…
2. A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Comb…
3. Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine
4. Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT
5. Post-Operative Nausea and Vomiting in Children Submitted to Strabismus Surgery